-
Active Stocks to Watch: Nexvet Biopharma Public Limited Company (NASDAQ:NVET), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), ImmunoGen (NASDAQ:IMGN), AECOM (NYSE:ACM), Compass Minerals International (NYSE:CMP)
Nexvet Biopharma Public Limited Company (NASDAQ:NVET) in last trading activity moved down -10.95% to close at $8.46. Company weekly performance is -17.62%. Nexvet Biopharma Public Limited Company (NASDAQ:NVET) is -23.09% away from its 52 week high. On March 13, Veterinary biologic therapy developer Nexvet Biopharma (NASDAQ:NVET) announced its financial results for the three and six…
-
Market Movers: ArQule Inc. (NASDAQ:ARQL), Verizon Communications Inc. (NYSE:VZ), Agria Corporation (NYSE:GRO), ImmunoGen (NASDAQ:IMGN), JPMorgan Chase & Co. (NYSE:JPM)
On March 04, ArQule Inc. (NASDAQ:ARQL) announced its financial results for the year and the fourth quarter ended December 31, 2014. The Company reported a net loss of $23,391,000 or $0.37 per share, for the year ended December 31, 2014, compared with a net loss of $24,600,000 or $0.39 per share, for the year ended…
-
Big Movers: ImmunoGen (NASDAQ:IMGN), VirtualScopics Inc. (NASDAQ:VSCP), Alleghany Corporation (NYSE:Y), Sage Therapeutics (NASDAQ:SAGE), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)
ImmunoGen, Inc. (NASDAQ:IMGN), announced Company management presented at Cowen and Company 35th Annual Health Care Conference in Boston, MA. On Monday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $7.89. Company’s sales growth for last 5 years was 16.40%. On 26 February, VirtualScopics Inc. (NASDAQ:VSCP) reported a net loss for the fourth quarter of $1.1 million,…
-
Stocks on the move: Koppers Holdings Inc. (NYSE:KOP), Staples (NASDAQ:SPLS), IHS Inc. (NYSE:IHS), Sony Corp (ADR) (NYSE:SNE), Tesla Motors Inc (NASDAQ:TSLA)
Koppers Holdings Inc. (NYSE:KOP) said it will suspend its dividend and consider selling some non-core assets as part of an initiative to pay down debt. In its fourth-quarter earnings statement, the Downtown-based maker of chemicals and wood treatment products said it wants to reduce debt by $200 to $250 million over the next two years.…
-
Stocks Gaining Momentum: Acorda Therapeutics (NASDAQ:ACOR), ImmunoGen (NASDAQ:IMGN), LCNB (NASDAQ:LCNB), Liberty Interactive Corp (NASDAQ:LVNTA), Stepan Company (NYSE:SCL)
Acorda Therapeutics, Inc. (NASDAQ:ACOR) announced that Michael Rogers, Chief Financial Officer, and Andrew Blight, Chief Scientific Officer, will present at the 2015 Leerink Global Healthcare Conference in New York on Thursday, February 12 at 1:50pm. On Tuesday shares of Acorda Therapeutics, Inc. (NASDAQ:ACOR) closed at $36.06. Company’s sales growth for last 5 years was 47.70%…
-
Stock Alert: Borderfree (NASDAQ:BRDR), ImmunoGen (NASDAQ:IMGN), Alcatel Lucent SA (ADR) (NYSE:ALU), Western Gas Partners LP (NYSE:WES), Micron Technology (NASDAQ:MU)
On 26 January, Borderfree, Inc. (NASDAQ:BRDR) announced that it has made an inducement equity award to Andre Schmidt, a new employee in connection with its acquisition of Bundle Tech Limited. Mr. Schmidt was the founder and chief executive officer of Bundle Tech Limited. On Friday shares of Borderfree, Inc. (NASDAQ:BRDR) closed at $5.85. Company’s EPS…
-
Premarket Gainers to Watch: ImmunoGen (NASDAQ:IMGN), Energy XXI Ltd (NASDAQ:EXXI), Linn Energy, LLC (NASDAQ:LINE), Immunomedics Inc. (NASDAQ:IMMU), FireEye (NASDAQ:FEYE)
ImmunoGen, Inc. (NASDAQ:IMGN) announced that the Company hosted a conference call at 8:00 a.m. ET on Friday, January 30, 2015, to discuss ImmunoGen’s financial results for the three-month period ended December 31, 2014, the second quarter of its 2015 fiscal year. Management will also provide an update on the Company. On Thursday shares of ImmunoGen,…
-
Watch 5 Stocks: ImmunoGen (NASDAQ:IMGN), Roka Bioscience (NASDAQ:ROKA), Huntsman Corporation (NYSE:HUN), Montpelier Re Holdings (NYSE:MRH), Citigroup Inc. (NYSE:C)
ImmunoGen, Inc. (NASDAQ:IMGN) announced that the Company following management will present at Leerink Global Healthcare Conference, on February 12 in New York, NY. On Thursday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $7.29. Company’s sales growth for last 5 years was 16.40%. Roka Bioscience, Inc. (NASDAQ: ROKA), announced that Mary Duseau has been named Senior…
-
Stocks in news: JD.com (NASDAQ:JD), ADTRAN Inc. (NASDAQ:ADTN), EOG Resources (NYSE:EOG), LRAD Corporation (NASDAQ:LRAD), ImmunoGen (NASDAQ:IMGN)
JD.com, Inc. (NASDAQ:JD) announced the launch of French Mall, a platform on JD.com dedicated exclusively to sales of authentic imported French products. JD.com launched French Mallat an event in Paris where JD.com Founder and CEO Richard Liu was joined by Senator Jean-Claude Lenoir, President of the Senate Committee on Economic Affairs; former Minister Patrick Devedjian;…
-
Sizzling Stocks: ImmunoGen (NASDAQ:IMGN), The Boeing Company (NYSE:BA), ERBA Diagnostics (NYSEMKT:ERB), Merck & Co. Inc. (NYSE:MRK), Gildan Activewear Inc. (NYSE:GIL)
ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, reported financial results for the three-month period ended December 31, 2014 — the second quarter of the Company’s 2015 fiscal year (2QFY2015). For the Company’s quarter ended December 31, 2014 (2QFY2015), ImmunoGen reported net income of $13.6 million,…